719 related articles for article (PubMed ID: 16151014)
21. Discontinued postnatal thymocyte development in sphingosine 1-phosphate-lyase-deficient mice.
Weber C; Krueger A; Münk A; Bode C; Van Veldhoven PP; Gräler MH
J Immunol; 2009 Oct; 183(7):4292-301. PubMed ID: 19748984
[TBL] [Abstract][Full Text] [Related]
22. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.
Pappu R; Schwab SR; Cornelissen I; Pereira JP; Regard JB; Xu Y; Camerer E; Zheng YW; Huang Y; Cyster JG; Coughlin SR
Science; 2007 Apr; 316(5822):295-8. PubMed ID: 17363629
[TBL] [Abstract][Full Text] [Related]
23. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions.
Vogel P; Donoviel MS; Read R; Hansen GM; Hazlewood J; Anderson SJ; Sun W; Swaffield J; Oravecz T
PLoS One; 2009; 4(1):e4112. PubMed ID: 19119317
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.
Rosen H; Goetzl EJ
Nat Rev Immunol; 2005 Jul; 5(7):560-70. PubMed ID: 15999095
[TBL] [Abstract][Full Text] [Related]
25. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.
Cyster JG; Schwab SR
Annu Rev Immunol; 2012; 30():69-94. PubMed ID: 22149932
[TBL] [Abstract][Full Text] [Related]
26. Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors.
Loetscher E; Schneider K; Beerli C; Billich A
Biochem Biophys Res Commun; 2013 Apr; 433(3):345-8. PubMed ID: 23499842
[TBL] [Abstract][Full Text] [Related]
27. Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities.
Fujii Y; Hirayama T; Ohtake H; Ono N; Inoue T; Sakurai T; Takayama T; Matsumoto K; Tsukahara N; Hidano S; Harima N; Nakazawa K; Igarashi Y; Goitsuka R
J Immunol; 2012 Jan; 188(1):206-15. PubMed ID: 22131329
[TBL] [Abstract][Full Text] [Related]
28. Elevated intrathymic sphingosine-1-phosphate promotes thymus involution during sepsis.
Kuchler L; Sha LK; Giegerich AK; Knape T; Angioni C; Ferreirós N; Schmidt MV; Weigert A; Brüne B; von Knethen A
Mol Immunol; 2017 Oct; 90():255-263. PubMed ID: 28846923
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine 1-phosphate and its type 1 G protein-coupled receptor: trophic support and functional regulation of T lymphocytes.
Goetzl EJ; Gräler MH
J Leukoc Biol; 2004 Jul; 76(1):30-5. PubMed ID: 14982946
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress.
Zamora-Pineda J; Kumar A; Suh JH; Zhang M; Saba JD
J Exp Med; 2016 Nov; 213(12):2773-2791. PubMed ID: 27810923
[TBL] [Abstract][Full Text] [Related]
31. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement.
Vora KA; Nichols E; Porter G; Cui Y; Keohane CA; Hajdu R; Hale J; Neway W; Zaller D; Mandala S
J Leukoc Biol; 2005 Aug; 78(2):471-80. PubMed ID: 15894589
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.
Bagdanoff JT; Donoviel MS; Nouraldeen A; Tarver J; Fu Q; Carlsen M; Jessop TC; Zhang H; Hazelwood J; Nguyen H; Baugh SD; Gardyan M; Terranova KM; Barbosa J; Yan J; Bednarz M; Layek S; Courtney LF; Taylor J; Digeorge-Foushee AM; Gopinathan S; Bruce D; Smith T; Moran L; O'Neill E; Kramer J; Lai Z; Kimball SD; Liu Q; Sun W; Yu S; Swaffield J; Wilson A; Main A; Carson KG; Oravecz T; Augeri DJ
J Med Chem; 2009 Jul; 52(13):3941-53. PubMed ID: 19489538
[TBL] [Abstract][Full Text] [Related]
33. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate.
Mendoza A; Bréart B; Ramos-Perez WD; Pitt LA; Gobert M; Sunkara M; Lafaille JJ; Morris AJ; Schwab SR
Cell Rep; 2012 Nov; 2(5):1104-10. PubMed ID: 23103166
[TBL] [Abstract][Full Text] [Related]
34. Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis.
Kariya Y; Kihara A; Ikeda M; Kikuchi F; Nakamura S; Hashimoto S; Choi CH; Lee YM; Igarashi Y
Genes Cells; 2005 Jun; 10(6):605-15. PubMed ID: 15938718
[TBL] [Abstract][Full Text] [Related]
35. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
36. S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing.
Ryser MF; Ugarte F; Lehmann R; Bornhäuser M; Brenner S
Mol Immunol; 2008 Nov; 46(1):166-71. PubMed ID: 18760838
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
King A; Houlihan DD; Kavanagh D; Haldar D; Luu N; Owen A; Suresh S; Than NN; Reynolds G; Penny J; Sumption H; Ramachandran P; Henderson NC; Kalia N; Frampton J; Adams DH; Newsome PN
Gastroenterology; 2017 Jul; 153(1):233-248.e16. PubMed ID: 28363640
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme.
Ikeda M; Kihara A; Kariya Y; Lee YM; Igarashi Y
Biochem Biophys Res Commun; 2005 Apr; 329(2):474-9. PubMed ID: 15737611
[TBL] [Abstract][Full Text] [Related]
39. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate.
Dueñas AI; Aceves M; Fernández-Pisonero I; Gómez C; Orduña A; Crespo MS; García-Rodríguez C
Cardiovasc Res; 2008 Aug; 79(3):537-44. PubMed ID: 18411230
[TBL] [Abstract][Full Text] [Related]
40. FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Schluesener HJ
Neuropathol Appl Neurobiol; 2009 Oct; 35(5):487-95. PubMed ID: 19207263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
